730
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Serum trimethylamine-N-oxide and protein energy wasting: some factors that should be considered

, , , , , , & show all
Article: 2165446 | Received 25 Oct 2022, Accepted 02 Jan 2023, Published online: 08 Feb 2023

References

  • Hu C, Zhang Y, Bi X, et al. Correlation between serum trimethylamine-N-oxide concentration and protein energy wasting in patients on maintenance hemodialysis. Ren Fail. 2022;44(1):1669–1676.
  • Stubbs JR, House JA, Ocque AJ, et al. Serum trimethylamine N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. J Am Soc Nephrol. 2016;27(1):305–313.
  • Hai X, Landeras V, Dobre MA, et al. Mechanism of prominent trimethylamine oxide (TMAO) accumulation in hemodialysis patients. PLOS One. 2015;10(12):e0143731.
  • Pelletier CC, Croyal M, Ene L, et al. Elevation of trimethylamine-N-oxide in chronic kidney disease: contribution of decreased glomerular filtration rate. Toxins. 2019;11(11):635.
  • Dai L, Meijers BK, Bammens B, et al. Sevelamer use in end-stage kidney disease (ESKD) patients associates with poor vitamin K status and high levels of gut-derived uremic toxins: a drug–bug interaction? Toxins. 2020;12(6):351.
  • Lin TY, Hung SC. Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study. Nephrol Dial Transplant. 2021;36(6):1104–1111.
  • Kalagi NA, Abbott KA, Alburikan KA, et al. Modulation of circulating trimethylamine N-oxide concentrations by dietary supplements and pharmacological agents: a systematic review. Adv Nutr. 2019;10(5):876–887.
  • Missailidis C, Hallqvist J, Qureshi AR, et al. Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLOS One. 2016;11(1):e0141738.
  • Sabatino A, Regolisti G, Karupaiah T, et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–671.